Watchlist Price Alert

Aquestive Therapeutics In... (AQST)

NASDAQ: AQST · Real-Time Price · USD

2.35

-0.03 (-1.26%)

At close: May 16, 2025, 3:59 PM

2.44

3.61%

After-hours: May 16, 2025, 07:13 PM EDT

Aquestive Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	71.55M	23.87M	27.27M	28.02M	31.81M	49.33M	60.6M	17.38M	9.21M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	5M	6M	7M	n/a	n/a	n/a	n/a
Other Long-Term Assets	4.22M	5.44M	6.45M	6.9M	7.84M	n/a	239K	1.24M	630K
Receivables	7.34M	8.47M	4.7M	12.12M	6.96M	13.13M	6.48M	6.18M	10.82M
Inventory	6.04M	6.77M	5.78M	4.04M	2.46M	2.86M	5.44M	4.01M	2.89M
Other Current Assets	3.29M	1.85M	2.13M	3.08M	3.4M	3M	1.68M	n/a	59K
Total Current Assets	88.22M	40.97M	39.89M	47.26M	44.63M	68.31M	74.2M	28.16M	23.33M
Property-Plant & Equipment	8.98M	9.74M	7.9M	7.78M	10.32M	9.73M	12.21M	13.46M	15.12M
Goodwill & Intangibles	n/a	1.28M	1.44M	51K	102K	439K	204K	254K	305K
Total Long-Term Assets	13.2M	16.45M	15.79M	14.73M	18.26M	10.16M	12.65M	14.95M	16.06M
Total Assets	101.42M	57.42M	55.67M	61.99M	62.88M	78.48M	86.85M	43.12M	39.39M
Account Payables	10.29M	8.93M	9.95M	8.31M	7.09M	12.27M	20.44M	9.6M	6.64M
Deferred Revenue	1.05M	1.55M	1.51M	765K	693K	806K	721K	1.35M	802K
Short-Term Debt	536K	22K	18.7M	2.02M	2.58M	n/a	4.6M	n/a	n/a
Other Current Liabilities	6.63M	5.12M	7.54M	7.19M	7.78M	1.72M	3.59M	597K	n/a
Total Current Liabilities	18.86M	18.31M	39.68M	21.96M	21.1M	18.55M	32.95M	15.35M	10.81M
Long-Term Debt	32.5M	27.51M	97.56M	110.61M	81.85M	60.34M	42.6M	45.51M	38.65M
Other Long-Term Liabilities	85.24M	80.34M	2.03M	2.48M	1.95M	1.36M	1.22M	8.75M	7.51M
Total Long-Term Liabilities	142.72M	145.6M	134.55M	122.16M	90.28M	66.05M	43.82M	54.26M	46.16M
Total Liabilities	161.58M	163.91M	174.23M	144.13M	111.38M	84.6M	76.77M	69.61M	56.97M
Total Debt	38M	33.32M	56.09M	56.42M	40.48M	60.34M	47.2M	45.51M	38.65M
Common Stock	91K	69K	55K	41K	35K	34K	25K	12.73M	11.24M
Retained Earnings	-363.21M	-319.08M	-311.21M	-256.8M	-186.26M	-130.47M	-61.38M	-120.09M	-108.67M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	-35.19M	-32.01M	-28.25M
Shareholders Equity	-60.16M	-106.49M	-118.55M	-82.13M	-48.5M	-6.12M	10.08M	-26.5M	-17.58M
Total Investments	n/a	4M	5M	6M	7M	n/a	n/a	n/a	n/a